Sobre
Dr Panagiotis Koliou is a highly experienced Consultant Medical Oncologist with over 17 years of clinical practice, specialising in the management of early and advanced breast cancer. He is recognised for delivering personalised, evidence-based care, combining the latest advances in oncology with a compassionate, patient-centred approach.
His expertise spans the full range of systemic anticancer treatments, including endocrine therapy, chemotherapy, antibody–drug conjugates, targeted therapies and immunotherapy. Dr Koliou treats patients across both standard care pathways and cutting-edge clinical trials, ensuring access to the most innovative therapies available.
Dr Koliou graduated in Medicine from the University of Ioannina and holds an honours degree in Biochemistry from Benedictine University, USA. He completed a Master’s degree in Clinical Biochemistry and Molecular Biology at the University of Surrey and was awarded a PhD in Medical Oncology with First Class honours from University of Ioannina, Greece. He undertook specialist training in Medical Oncology at the Aristotle University of Thessaloniki in Greece and at University College London Hospital.
He has a strong interest in precision oncology, using advanced molecular and genomic profiling to tailor treatments to each individual patient. His work incorporates the use of circulating tumour DNA and other liquid biopsy technologies to guide treatment decisions and monitor disease in real time.
Dr Koliou has extensive experience in managing complex metastatic breast cancer, with particular expertise in sequencing therapies and optimising outcomes across multiple lines of treatment. He is also an active contributor to research and innovation, having served as Principal Investigator in multiple Phase III clinical trials in breast cancer and melanoma at Royal Surrey, helping to bring forward new standards of care.
Known for his clarity, attention to detail and commitment to excellence, Dr Koliou works closely with multidisciplinary teams to ensure each patient receives the highest standard of care throughout their treatment journey.
His expertise spans the full range of systemic anticancer treatments, including endocrine therapy, chemotherapy, antibody–drug conjugates, targeted therapies and immunotherapy. Dr Koliou treats patients across both standard care pathways and cutting-edge clinical trials, ensuring access to the most innovative therapies available.
Dr Koliou graduated in Medicine from the University of Ioannina and holds an honours degree in Biochemistry from Benedictine University, USA. He completed a Master’s degree in Clinical Biochemistry and Molecular Biology at the University of Surrey and was awarded a PhD in Medical Oncology with First Class honours from University of Ioannina, Greece. He undertook specialist training in Medical Oncology at the Aristotle University of Thessaloniki in Greece and at University College London Hospital.
He has a strong interest in precision oncology, using advanced molecular and genomic profiling to tailor treatments to each individual patient. His work incorporates the use of circulating tumour DNA and other liquid biopsy technologies to guide treatment decisions and monitor disease in real time.
Dr Koliou has extensive experience in managing complex metastatic breast cancer, with particular expertise in sequencing therapies and optimising outcomes across multiple lines of treatment. He is also an active contributor to research and innovation, having served as Principal Investigator in multiple Phase III clinical trials in breast cancer and melanoma at Royal Surrey, helping to bring forward new standards of care.
Known for his clarity, attention to detail and commitment to excellence, Dr Koliou works closely with multidisciplinary teams to ensure each patient receives the highest standard of care throughout their treatment journey.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Panagiotis Koliou
Educação e formação
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Oncologia
Carreira e nomeações
-
2027-09–2028-08 Junior consultant
Licenças e seguros
Licenças médicas
GB — Organización Médica Colegial de España (OMC)
Certificações do conselho
European Board of Oncologia
Seguro de responsabilidade profissional:
Generali Healthcare · 5,000,000 EUR cobertura · No claims on file
Procedimentos realizados
| Procedimento | Código | Total acumulado |
|---|---|---|
| GP consultation | 99213 | 1,257 |
| Annual physical exam | 99395 | 2,071 |
| Vaccination administration | 90471 | 207 |
| Minor procedure (skin) | 17110 | 1,152 |
Serviços e preços
| Serviço | Duração | Modalidade | Preço |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 720.00 EUR |
Consultório, equipa e na prática
Vídeos
Investigação e publicações
índice h: 16 · i10: 7
-
Validation of clinical scoring in Oncologia
DOI: 10.8522/euroclin.2026.0 · PMID: 31811256 · citado por 17
-
Long-term follow-up of Oncologia across GB
DOI: 10.8605/euroclin.2025.1 · PMID: 35432255 · citado por 51
-
Validation of clinical scoring in Oncologia
DOI: 10.8463/euroclin.2024.2 · PMID: 38956036 · citado por 29
Palestras convidadas
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · Guildford · 2023 · oral abstract
Prémios e afiliações
Prémios
- 🏆 Top-rated Oncologia — Guildford · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Filiações em sociedades
- WONCA Europe — Family Doctors — Member · Desde 2028
- national college of family doctors — Member · Desde 2028
- European Union of Medical Specialists (UEMS) — Member · Desde 2028
Artigos deste médico
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
Para pacientes internacionais
- Coordenador
- Patient liaison · panagiotis.koliou@euroclinics.example
- Seguros internacionais aceites
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Localização
1 etiquetaAvaliações dos pacientes
18 avaliações verificadas5.00
★★★★★
18 avaliações
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Partilhe a sua experiência — ajude outros pacientes a encontrar o médico certo. Escrever uma avaliação →
Avaliações recentes
-
★★★★★ ✓ Verificado Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificado Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificado Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Especialistas semelhantes
Ver todos →
Mr Abdulla Alhasso
Oncologia · Glasgow
Dr Alexander McDonald
Oncologia · Glasgow
Dr Amna Sheri
Oncologia · London
Dr Angus Robinson
Oncologia · Horley
Dr Anne Armstrong
Oncologia · Manchester
Dr Ashraf Azzabi
Oncologia · Washington
Dr Clare Green
Oncologia · Winchester
Dr Desmond Yip
Oncologia · Garran